Literature DB >> 15922951

The 'supervirus'? Lessons from IL-4-expressing poxviruses.

Marianne M Stanford1, Grant McFadden.   

Abstract

Members of the Poxviridae family are particularly adept at avoiding the host immune system, encoding a plethora of immunomodulatory proteins that subvert host defense. With their large genome, poxviruses are also useful for studying the effect of exogenous genes on virus-host interactions and immune responses. The insertion of the Th2 cytokine interleukin-4 (IL-4) into several poxviruses significantly increases the efficiency of the recombinant virus as a pathogen by directly inhibiting the development of Th1 immunity, which is crucial for viral clearance. In an age in which the fear of genetically modified weaponized pathogens exists, the understanding of how to make viruses more pathogenic further blurs the distinction between fundamental academic research and bioweapons development. Here, the extent of immune evasion by IL-4-expressing poxviruses will be explored, as will the consequences of this increased pathogenicity on protective immune responses.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15922951     DOI: 10.1016/j.it.2005.04.001

Source DB:  PubMed          Journal:  Trends Immunol        ISSN: 1471-4906            Impact factor:   16.687


  9 in total

1.  The biological century: coming to terms with risk in the life sciences.

Authors:  David A Relman
Journal:  Nat Immunol       Date:  2010-04       Impact factor: 25.606

2.  T-bet is required for protection against vaccinia virus infection.

Authors:  Masanori Matsui; Osamu Moriya; Takayuki Yoshimoto; Toshitaka Akatsuka
Journal:  J Virol       Date:  2005-10       Impact factor: 5.103

3.  Generation of recombinant vaccinia viruses via green fluorescent protein selection.

Authors:  Sergei Popov; Saied Mirshahidi; Sosthène Essono; Ruijiang Song; Xiaowei Wang; Ruth M Ruprecht
Journal:  DNA Cell Biol       Date:  2009-03       Impact factor: 3.311

4.  Second-generation HIF-activated oncolytic adenoviruses with improved replication, oncolytic, and antitumor efficacy.

Authors:  T Cherry; S L Longo; Z Tovar-Spinoza; D E Post
Journal:  Gene Ther       Date:  2010-07-22       Impact factor: 5.250

5.  Myxoma virus expressing human interleukin-12 does not induce myxomatosis in European rabbits.

Authors:  Marianne M Stanford; John W Barrett; Philippe-Alexandre Gilbert; Richard Bankert; Grant McFadden
Journal:  J Virol       Date:  2007-08-29       Impact factor: 5.103

6.  Poxvirus interleukin-4 expression overcomes inherent resistance and vaccine-induced immunity: pathogenesis, prophylaxis, and antiviral therapy.

Authors:  Nanhai Chen; Clifford J Bellone; Jill Schriewer; Gelita Owens; Torgny Fredrickson; Scott Parker; R Mark L Buller
Journal:  Virology       Date:  2010-11-10       Impact factor: 3.513

Review 7.  The evolution of poxvirus vaccines.

Authors:  Lucas Sánchez-Sampedro; Beatriz Perdiguero; Ernesto Mejías-Pérez; Juan García-Arriaza; Mauro Di Pilato; Mariano Esteban
Journal:  Viruses       Date:  2015-04-07       Impact factor: 5.048

Review 8.  Poxvirus Host Range Genes and Virus-Host Spectrum: A Critical Review.

Authors:  Graziele Pereira Oliveira; Rodrigo Araújo Lima Rodrigues; Maurício Teixeira Lima; Betânia Paiva Drumond; Jônatas Santos Abrahão
Journal:  Viruses       Date:  2017-11-07       Impact factor: 5.048

Review 9.  Hazard Characterization of Modified Vaccinia Virus Ankara Vector: What Are the Knowledge Gaps?

Authors:  Malachy I Okeke; Arinze S Okoli; Diana Diaz; Collins Offor; Taiwo G Oludotun; Morten Tryland; Thomas Bøhn; Ugo Moens
Journal:  Viruses       Date:  2017-10-29       Impact factor: 5.048

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.